The Relationship Between Acrolein and Oxidative Stress in COPD: in Systemic Plasma and in Local Lung Tissue

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2019 Aug 3

PMID 31371938

Citations 13

Authors

Masanori Yasuo

Yunden Droma

Yoshiaki Kitaguchi

Michiko Ito

Hitomi Imamura

Masatomo Kawakubo

Masayuki Hanaoka

Affiliations

Soon will be listed here.

Abstract

Purpose: Cigarette smoke produces a high level of acrolein, which is thought to be pathogenically involved in the development of chronic obstructive pulmonary disease (COPD). The present study investigated the pathological role of acrolein in the development of COPD.

Patients And Methods: Acrolein concentration was measured in plasmas obtained from 47 patients with COPD and 18 current smokers without COPD, and in supernatants of homogenized lung tissues obtained from 10 never-smokers, 8 current smokers, and 8 patients with COPD by high-performance liquid chromatography. Oxidant status and antioxidant activity were measured using derivatives of reactive oxygen metabolite (d-ROM) and bio-antioxidant power (BAP), respectively, in the Free Radical Elective Evaluation FRAS4 system. In addition, immunohistochemistry was used to evaluate the over-presentation of acrolein in lung tissues of patients with COPD.

Results: Plasma concentrations of acrolein were significantly higher in the patients with COPD than the non-COPD smokers (<0.001), which significantly correlated with the oxidant status in patients with COPD (R=0.69, <0.05). Similar pathological alterations in acrolein concentrations were found in the lung tissue supernatants of patients with COPD, which significantly correlated with the oxidant status in patients with COPD. Furthermore, acrolein was strongly expressed in the lung tissues of patients with COPD.

Conclusion: The increased acrolein concentrations were highly involved in the pathogenesis of COPD through interference in the balance of oxidative stress versus antioxidant potentiality.

Citing Articles

Plasmid-encoded toxin defence mediates mutualistic microbial interactions.

Morais S, Mazor M, Tovar-Herrera O, Zehavi T, Zorea A, Ifrach M Nat Microbiol. 2023; 9(1):108-119.

PMID: 38151647 PMC: 10769881. DOI: 10.1038/s41564-023-01521-9.

Diet as a Source of Acrolein: Molecular Basis of Aldehyde Biological Activity in Diabetes and Digestive System Diseases.

Hikisz P, Jacenik D Int J Mol Sci. 2023; 24(7).

PMID: 37047550 PMC: 10095194. DOI: 10.3390/ijms24076579.

The Tobacco Smoke Component, Acrolein, as a Major Culprit in Lung Diseases and Respiratory Cancers: Molecular Mechanisms of Acrolein Cytotoxic Activity.

Hikisz P, Jacenik D Cells. 2023; 12(6).

PMID: 36980220 PMC: 10047238. DOI: 10.3390/cells12060879.

Disruption of the Molecular Regulation of Mitochondrial Metabolism in Airway and Lung Epithelial Cells by Cigarette Smoke: Are Aldehydes the Culprit?.

Tulen C, Opperhuizen A, van Schooten F, Remels A Cells. 2023; 12(2).

PMID: 36672235 PMC: 9857032. DOI: 10.3390/cells12020299.

Urinary volatile organic compound metabolites and reduced lung function in U.S. adults.

Mendy A, Burcham S, Merianos A, Mersha T, Mahabee-Gittens E, Chen A Respir Med. 2022; 205:107053.

PMID: 36399896 PMC: 9869342. DOI: 10.1016/j.rmed.2022.107053.

References

Benzie I, Strain J . The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239(1):70-6. DOI: 10.1006/abio.1996.0292. View

Eiserich J, van der Vliet A, Handelman G, Halliwell B, Cross C . Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr. 1995; 62(6 Suppl):1490S-1500S. DOI: 10.1093/ajcn/62.6.1490S. View

Bein K, Leikauf G . Acrolein - a pulmonary hazard. Mol Nutr Food Res. 2011; 55(9):1342-60. DOI: 10.1002/mnfr.201100279. View

Carmella S, Chen M, Zhang Y, Zhang S, Hatsukami D, Hecht S . Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol. 2007; 20(7):986-90. PMC: 2556963. DOI: 10.1021/tx700075y. View

Deshmukh H, Shaver C, Case L, Dietsch M, Wesselkamper S, Hardie W . Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol. 2007; 38(4):446-54. PMC: 2274947. DOI: 10.1165/rcmb.2006-0339OC. View

Andreoli R, Manini P, Corradi M, Mutti A, Niessen W . Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2003; 17(7):637-45. PMC: 1455504. DOI: 10.1002/rcm.960. View

Rahman I . Antioxidant therapies in COPD. Int J Chron Obstruct Pulmon Dis. 2007; 1(1):15-29. PMC: 2706605. DOI: 10.2147/copd.2006.1.1.15. View

Kubota M, Kobayashi H, Quanjer P, Omori H, Tatsumi K, Kanazawa M . Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014; 52(4):242-50. DOI: 10.1016/j.resinv.2014.03.003. View

Vogelmeier C, Criner G, Martinez F, Anzueto A, Barnes P, Bourbeau J . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017; 195(5):557-582. DOI: 10.1164/rccm.201701-0218PP. View

10.

Agusti A, Soriano J . COPD as a systemic disease. COPD. 2008; 5(2):133-8. DOI: 10.1080/15412550801941349. View

11.

Moretto N, Volpi G, Pastore F, Facchinetti F . Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2012; 1259:39-46. DOI: 10.1111/j.1749-6632.2012.06531.x. View

12.

Valavanidis A, Vlachogianni T, Fiotakis K . Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health. 2009; 6(2):445-62. PMC: 2672368. DOI: 10.3390/ijerph6020445. View

13.

Vassalle C, Boni C, Di Cecco P, Ndreu R, Carlo Zucchelli G . Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clin Chem Lab Med. 2006; 44(11):1372-5. DOI: 10.1515/CCLM.2006.243. View

14.

Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y . Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A. 1998; 95(9):4882-7. PMC: 20182. DOI: 10.1073/pnas.95.9.4882. View

15.

Sievi N, Senn O, Brack T, Brutsche M, Frey M, Irani S . Impact of comorbidities on physical activity in COPD. Respirology. 2015; 20(3):413-8. DOI: 10.1111/resp.12456. View

16.

Stevens J, Maier C . Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 2008; 52(1):7-25. PMC: 2423340. DOI: 10.1002/mnfr.200700412. View

17.

Antus B, Kardos Z . Oxidative stress in COPD: molecular background and clinical monitoring. Curr Med Chem. 2015; 22(5):627-50. DOI: 10.2174/092986732205150112104411. View

18.

Rahman I . Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys. 2005; 43(1):167-88. DOI: 10.1385/CBB:43:1:167. View

19.

Hanaoka M, Droma Y, Chen Y, Agatsuma T, Kitaguchi Y, Voelkel N . Carbocisteine protects against emphysema induced by cigarette smoke extract in rats. Chest. 2010; 139(5):1101-1108. DOI: 10.1378/chest.10-0920. View